Evidence map›Paper›PMID 33992612›Full record

ArticleAmerican journal of ophthalmology2021

Importance and Severity Dependence of Physical Activity by GPS-Tracked Location in Glaucoma Patients.

Jian-Yu E, Aleksandra Mihailovic, Catalina Garzon, Jennifer A Schrack, Tianjing Li, Sheila K West, David S Friedman, Laura N Gitlin, Pradeep Y Ramulu

Open access · greenAbstract read
In one paragraph

Article in American journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Jian-Yu EWilmer Eye Institute, Johns Hopkins University School of Medicine (J.-Y.E., A.M., C.G., S.K.W., P.Y.R.); Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (J.-Y.E., J.A.S., P.Y.R.).
Aleksandra MihailovicWilmer Eye Institute, Johns Hopkins University School of Medicine (J.-Y.E., A.M., C.G., S.K.W., P.Y.R.).
Catalina GarzonWilmer Eye Institute, Johns Hopkins University School of Medicine (J.-Y.E., A.M., C.G., S.K.W., P.Y.R.).
Jennifer A SchrackDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (J.-Y.E., J.A.S., P.Y.R.); Center on Aging and Health, Johns Hopkins University, Baltimore, Maryland (J.A.S., P.Y.R.).
Tianjing LiDepartment of Ophthalmology, School of Medicine, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, USA (T.L.).
Sheila K WestWilmer Eye Institute, Johns Hopkins University School of Medicine (J.-Y.E., A.M., C.G., S.K.W., P.Y.R.).
David S FriedmanMassachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts (D.S.F.).
Laura N GitlinCollege of Nursing and Health Professions, Drexel University, Philadelphia, Pennsylvania (L.N.G.).
Pradeep Y RamuluWilmer Eye Institute, Johns Hopkins University School of Medicine (J.-Y.E., A.M., C.G., S.K.W., P.Y.R.); Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (J.-Y.E., J.A.S., P.Y.R.); Center on Aging and Health, Johns Hopkins University, Baltimore, Maryland (J.A.S., P.Y.R.). Electronic address: pramulu@jhmi.edu.
Johns Hopkins Medicine · USJohns Hopkins University · USDrexel University · USHarvard University · USUniversity of Colorado Denver · US

Funding

Maximizing Use of High-Quality Evidence in Eye Care: Cochrane Eyes and Vision US ProjectUG1EY020522 · NEI · UNIVERSITY OF COLORADO DENVER · PI Tianjing Li · 2017 to 2026
$10.1M
Optimizing Safety and Functionality in the Visually ImpairedR01EY022976 · NEI · JOHNS HOPKINS UNIVERSITY · PI RAMULU, PRADEEP YAMMANURU · 2013 to 2024
$5.2M
NEI NIH HHS R01 EY022976NEI NIH HHS UG1 EY020522
6 · The paper itself

Abstract

purposeTo quantify the association of visual field (VF) damage on physical activity away-from-home, per away-from-home excursion, and at-home.

designProspective cohort study.

methodsAmong 229 participants with glaucoma or suspected glaucoma, the severity of VF damage was defined as average sensitivity within the integrated VF (IVF). Participants wore accelerometers and global positioning system trackers for 7 days to measure physical activity and characterize activity location. Multivariable negative binomial regressions were used to test whether away-from-home activity per day, physical activity per away-from-home excursion, and at-home activity per day varied by the severity of VF damage.

resultsEach 5-dB decrement in IVF sensitivity was associated with a lower number of away-from-home activities per day (18% less moderate and vigorous physical activity [MVPA] minutes/d, 95% confidence interval, 0.69-0.97) and physical activities per away-from-home excursion (20% less MVPA minutes/excursion, 95% confidence interval, 0.65-0.98). Similar findings were noted for other away-from-home activity measures (including active minutes/steps per day, or active minutes/steps per excursion). However, worse IVF sensitivity was not associated with measures of at-home activities (MVPA minutes/d, active minutes/d, and steps/d), time spent at or away from home, or excursions/wk (P > .1 for all).

conclusionsRestriction of physical activity in more patients with severe glaucoma results mostly from activity restriction outside the home environment. These findings highlight the importance of maintaining a safe home environment (where activity is less restricted) and increasing confidence to perform activity, particular high-intensity activity, when leaving the home amongst patients with glaucoma.

Indexed as

ExerciseGlaucomaHome EnvironmentHumansProspective StudiesVisual AcuityAccelerometer, Excursion, Home Activity, GPS, Mobility, Vision Impairment, Older Adults.

Identifiers

PMID33992612
PMCPMC8589895
OpenAlexW3162530669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.